Elements of Biopharmaceutical Production Series - - BioPharm International

ADVERTISEMENT

Elements of Biopharmaceutical Production Series


Articles from Elements of Biopharmaceutical Production series
by Anurag Rathore and coauthors

Key Considerations for Development and Production of Vaccine Products
March 2012

Development and Commercialization of Biosimilars in India
November 2011

Challenges and Trends in Vaccine Manufacturing
October 2011

Operational Excellence: More Data or Smarter Approach?
June 2011

PDA's New Technical Report for Biotech Cleaning Validation
March 2011

Achieving Process Intensification by Scheduling and Debottlenecking Biotech Processes
February 2011

Managing Raw Materials in the QbD Paradigm
Part 1: Understanding Risks: November 2010
Part 2: Risk Assessment and Communication: December 2010

Setting Specifications for a Biotech Therapeutic Product in the Quality by Design Paradigm
January 2010

Future Technologies for Efficient Manufacturing
February 2009

Quality by Design for Biopharmaceuticals:
Case Studies Part II
January 2009

Process Validation:
How much to Do and When to do it Quality by Design for Biopharmaceuticals: Defining Design Space
December 2008

Modeling of Microbial and Mammalian Unit Operations
Part I: June 2008

Modeling of Process Chromatography Unit Operation
Part II: August 2008

Filter Clogging Issues in Sterile Filtration
April 2008

Lifetime Studies for Membrane Reuse
September 2007

Quality: Design Space for Biotech Products
April 2007

Applications of MVDA in Biotech Processing
October 2007

Applying PAT to Biotech Unit Operations
August 2006

Efficiency Measurements for Chromatography Columns
August 2005

Scaling Down Fermentation
Part I: March 2005

Scaling Down Chromatography and Filtration
Part II: April 2005

Optimization, Scale-up, and Validation Issues in Filtration
Part I: August 2004
Part II: September 2004

Costing Issues in the Production of Biopharmaceuticals
February 2004

Economic Analysis as a Tool for Process Development

 

For the entire Elements of Biopharmaceutical Production series, please visit www.industrymatter.com/EBPseries.aspx

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million
October 28, 2014
Yale and Gilead Extend Sequencing Initiative
October 28, 2014
Author Guidelines

Click here